{
  "story_id": "de1a4e032d2d43a71c6473f39ddad742",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-11-20T13:00:17.000Z",
  "content_hash": "520bbfb28a228c76494deff8d7e0a286781b467484b1c35a9a3fc2ffb5f767f3",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Researchers develop promising blood test for living CTE diagnosis",
    "dek": "Boston University researchers identified a blood biomarker for detecting late stage CTE.",
    "prose": "Chronic traumatic encephalopathy (CTE) can currently only be diagnosed via autopsy after death. [^1]\n\nMichael Alosco, co-director of Boston University CTE Center, stated that a blood test for CTE could be a game changer. [^2] The CTE blood test is not approved by the US FDA and is not available for public diagnostic use. [^3] Researchers published a study in the Journal of the American Medical Association describing an experimental blood test for CTE. [^4]\n\nThe eMTBR-tau blood test did not detect early stage CTE or correctly rule out absence of CTE in the study cohort. [^5] Michael Alosco, study senior author, stated the test is not FDA approved and requires further large scale validation. [^6] The study analyzed blood samples from 21 deceased football players, 18 of whom had confirmed CTE at autopsy. [^7]\n\nThe test detects the eMTBR-tau biomarker, which is elevated in people with severe CTE. [^8]",
    "cited": "[{\"statement\":\"Chronic traumatic encephalopathy (CTE) can currently only be diagnosed via autopsy after death.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-20T13:00:17.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"],\"url\":\"https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html\"},{\"statement\":\"Michael Alosco, co-director of Boston University CTE Center, stated that a blood test for CTE could be a game changer.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-20T13:00:17.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"],\"url\":\"https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html\"},{\"statement\":\"The CTE blood test is not approved by the US FDA and is not available for public diagnostic use.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-20T13:00:17.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"],\"url\":\"https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html\"},{\"statement\":\"Researchers published a study in the Journal of the American Medical Association describing an experimental blood test for CTE.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T18:50:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"],\"url\":\"https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/\"},{\"statement\":\"The eMTBR-tau blood test did not detect early stage CTE or correctly rule out absence of CTE in the study cohort.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-20T13:00:17.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"],\"url\":\"https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html\"},{\"statement\":\"Michael Alosco, study senior author, stated the test is not FDA approved and requires further large scale validation.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T18:50:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"],\"url\":\"https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/\"},{\"statement\":\"The study analyzed blood samples from 21 deceased football players, 18 of whom had confirmed CTE at autopsy.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T18:50:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"],\"url\":\"https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/\"},{\"statement\":\"The test detects the eMTBR-tau biomarker, which is elevated in people with severe CTE.\",\"source\":\"Scientific American\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T18:50:00.000Z\",\"publisher_count\":1,\"sources\":[\"Scientific American\"],\"url\":\"https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/\"}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": {
    "slice_hash": "508ede594663fd69c48076e5f2b61f9f1bdc0785cae285f028be62defe38d4d3",
    "cursor_from": "ingest:raw_newsroomfloor.stories:508ede594663fd69",
    "cursor_to": "ingest:raw_newsroomfloor.stories:508ede594663fd69",
    "view": "ingest:raw_newsroomfloor.stories",
    "view_version": "1",
    "row_count": 1,
    "hash_basis": "sha256 over the JSON array of {insertId, json} rows as received (normalized wire shape), computed before the BigQuery forward",
    "credits": 0.01,
    "price_per_100_rows_written": 1,
    "sig": "Q_1kg9RmYNfzQtyX1fskvXoc8YSFh8o0bJr7X2mFvXPQIlpl4GeC676ZwY4PP9Ku9wQI0nFw_FaS8hR2qqlLDg",
    "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
    "signer_path": "lakehouse/data-extract/v1",
    "alg": "Ed25519",
    "signed": true
  },
  "receipt_note": "the ingest door's signed receipt for this revision, verbatim as the door returned it",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "670dd0247b638e08122c9c60b9f0fa29",
      "thread_id": "219ae76cc10864a5e1f07f9e21b31c3c",
      "thread_label": "Boston University CTE Center",
      "novelty": "UPDATE",
      "content_hash": "6d7dd252b195c781db45ab54f07cc2206851d0e349e4490e052ddf668d2dce57",
      "compose": 3,
      "last_published_at": "2026-11-20T13:00:17.000Z",
      "read_receipt": {
        "slice_hash": "6dc2d9e58f101533d1e559a5955738d51186a526bc58d869d246f3a3b034ec0e",
        "cursor_from": "eyJ0cyI6IjIwMjYtMTEtMjBUMTI6MDQ6MDcuMDAwMDAwWiIsImlkIjoiN2RlMGFkNzY0ODgwMzFmOWU4ZjI4MjA3MDRmNzU2MWYiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMTEtMjBUMTc6Mzc6MTAuMDAwMDAwWiIsImlkIjoiOWVlYmVlZjgyMWM1MTExMmU1NzI0MDA2ZWNkYzhjZjEiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 85,
        "window_days": 3,
        "bytes_scanned": 0,
        "credits": 6.8,
        "price_per_100_rows": 8,
        "sig": "_hJHnighuv48Tg7XmmVqJF_QY2gY-AFadxPDapix90LcYk6X9YJMGLVZmqesd6RV_gEAnM7mie4fCM0smLPzCg",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "landing": "air"
    },
    "written_at": "2026-11-20T18:30:48.588Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "Chronic traumatic encephalopathy (CTE) can currently only be diagnosed via autopsy after death.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": "https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "Michael Alosco, co-director of Boston University CTE Center, stated that a blood test for CTE could be a game changer.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": "https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "The CTE blood test is not approved by the US FDA and is not available for public diagnostic use.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": "https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "Researchers published a study in the Journal of the American Medical Association describing an experimental blood test for CTE.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "The eMTBR-tau blood test did not detect early stage CTE or correctly rule out absence of CTE in the study cohort.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": "https://medicalxpress.com/news/2026-11-game-changer-blood-cte.html",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "Michael Alosco, study senior author, stated the test is not FDA approved and requires further large scale validation.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "The study analyzed blood samples from 21 deceased football players, 18 of whom had confirmed CTE at autopsy.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 8,
      "statement": "The test detects the eMTBR-tau biomarker, which is elevated in people with severe CTE.",
      "source": "Scientific American",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.scientificamerican.com/article/a-watershed-moment-researchers-unveil-first-of-its-kind-blood-test-for-cte/",
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}